148 related articles for article (PubMed ID: 34532898)
1. Chronic opioid use is associated with obstructive and spastic disorders in the esophagus.
Sanchez MJ; Olivier S; Gediklioglu F; Almeida M; Gaeta M; Nigro M; de la Rosa R; Nguyen M; Lalehzari M; Regala F; Njei B; Deng Y; Ciarleglio M; Masoud A
Neurogastroenterol Motil; 2022 Mar; 34(3):e14233. PubMed ID: 34532898
[TBL] [Abstract][Full Text] [Related]
2. Chronic daily opioid exposure is associated with dysphagia, esophageal outflow obstruction, and disordered peristalsis.
Babaei A; Szabo A; Shad S; Massey BT
Neurogastroenterol Motil; 2019 Jul; 31(7):e13601. PubMed ID: 30993800
[TBL] [Abstract][Full Text] [Related]
3. Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.
Ratuapli SK; Crowell MD; DiBaise JK; Vela MF; Ramirez FC; Burdick GE; Lacy BE; Murray JA
Am J Gastroenterol; 2015 Jul; 110(7):979-84. PubMed ID: 26032150
[TBL] [Abstract][Full Text] [Related]
4. Impact of opioids on esophageal motility.
Snyder DL; Vela MF
Neurogastroenterol Motil; 2023 May; 35(5):e14587. PubMed ID: 37060333
[TBL] [Abstract][Full Text] [Related]
5. Opioid Exposure Differentially Impacts Esophageal Body Contraction Over the Lower Esophageal Sphincter.
Patel DA; Goss J; Hayat M; Tombazzi C; Naik RD; Slaughter JC; Aslam M; Sarker S; Higginbotham T; Vaezi MF
Gastroenterology; 2022 Aug; 163(2):403-410. PubMed ID: 35537552
[TBL] [Abstract][Full Text] [Related]
6. Esophageal anatomy and physiology vary across spastic and non-spastic phenotypes of disorders of esophagogastric junction outflow.
Vahedi F; Low EE; Kaizer AM; Fehmi SA; Hasan A; Chang MA; Kwong W; Krinsky ML; Anand G; Greytak M; Yadlapati R
Neurogastroenterol Motil; 2024 Feb; 36(2):e14709. PubMed ID: 38009826
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review With Meta-Analysis: Chronic Opioid Use Is Associated With Esophageal Dysmotility in Symptomatic Patients.
Niu C; Zhang J; Bapaye J; Liu H; Zhu K; Farooq U; Zahid S; Zhang Q; Boppana H; Elkhapery A; Okolo PI
Am J Gastroenterol; 2023 Dec; 118(12):2123-2132. PubMed ID: 37463432
[TBL] [Abstract][Full Text] [Related]
8. Changes in the esophagogastric junction outflow obstruction manometric feature based on the Chicago Classification updates.
Li YY; Lu WT; Liu JX; Wu LH; Chen M; Jiao HM
World J Gastroenterol; 2022 Aug; 28(30):4163-4173. PubMed ID: 36157106
[TBL] [Abstract][Full Text] [Related]
9. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
10. Opioid-induced esophageal dysfunction.
Snyder DL; Vela MF
Curr Opin Gastroenterol; 2020 Jul; 36(4):344-350. PubMed ID: 32427604
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and impact of opioid use in patients undergoing peroral endoscopic myotomy.
Jacobs CC; Al-Haddad M; Stainko S; Perkins A; DeWitt JM
Gastrointest Endosc; 2023 Apr; 97(4):655-663.e2. PubMed ID: 36509112
[TBL] [Abstract][Full Text] [Related]
12. Incidence of opioid-induced esophageal dysfunction.
Ladrón Abia P; Ortiz V; García-Campos M; Saéz-González E; Mínguez Sabater A; Izquierdo R; Garrigues V
Gastroenterol Hepatol; 2023 Apr; 46(4):249-254. PubMed ID: 35605820
[TBL] [Abstract][Full Text] [Related]
13. Multiple Rapid Swallows (MRS) Complements Single-Swallow (SS) Analysis for High-Resolution Esophageal Manometry (HREM).
Leopold A; Yu D; Bhuta R; Kataria R; Lu X; Jehangir A; Harrison M; Friedenberg F; Malik Z; Schey R; Parkman HP
Dig Dis Sci; 2019 Aug; 64(8):2206-2213. PubMed ID: 30805798
[TBL] [Abstract][Full Text] [Related]
14. Bolus clearance in esophagogastric junction outflow obstruction is associated with strength of peristalsis.
Jain A; Baker JR; Rubenstein JH; Chen JW
Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28466506
[TBL] [Abstract][Full Text] [Related]
15. Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia.
Quader F; Mauro A; Savarino E; Tolone S; de Bortoli N; Franchina M; Ghisa M; Edelman K; Jha LK; Penagini R; Gyawali CP
Neurogastroenterol Motil; 2019 Sep; 31(9):e13678. PubMed ID: 31310444
[TBL] [Abstract][Full Text] [Related]
16. The Chicago Classification of esophageal motility disorders, v3.0.
Kahrilas PJ; Bredenoord AJ; Fox M; Gyawali CP; Roman S; Smout AJ; Pandolfino JE;
Neurogastroenterol Motil; 2015 Feb; 27(2):160-74. PubMed ID: 25469569
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases?
Marjoux S; Brochard C; Roman S; Gincul R; Pagenault M; Ponchon T; Ropert A; Mion F
Dis Esophagus; 2015; 28(8):735-41. PubMed ID: 25212219
[TBL] [Abstract][Full Text] [Related]
18. Lower prevalence of gastroesophageal reflux disease in patients with noncardiac chest pain on opiates: a cross-sectional study.
Cifuentes JDG; Thota PN; Lopez R
Dis Esophagus; 2018 Nov; 31(11):. PubMed ID: 29846541
[TBL] [Abstract][Full Text] [Related]
19. Primary Esophageal Motility Disorders: Beyond Achalasia.
Schlottmann F; Patti MG
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665309
[TBL] [Abstract][Full Text] [Related]
20. Esophageal motility disorders-Symptomatic and manometric spectrum in Punjab, northern India.
Goyal O; Bansal M; Sood A
Indian J Gastroenterol; 2017 May; 36(3):202-208. PubMed ID: 28593551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
